Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

KNSAKNSA
9 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in KINIKSA PHARMACEUTICALS INTL

Connor, Clark & Lunn Investment Management Ltd. holds 572,598 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $36.6M as of 2026-Q2. The position was decreased (-11.9% shares). KNSA represents 0.1% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.

Current Value

$36.6M

Current Shares

572,598

Total Value Change

+$32.3M

Total Shares Change

+341,519

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
572,598
-11.9%
$36.6M0.1%$63.95
0
2026-Q1
Decreased
649,629
-12.1%
$31.3M0.1%$45.37
0
2025-Q4
Increased
739,326
+1.9%
$30.5M0.1%$40.99
29
2025-Q3
Increased
725,355
+16.3%
$28.2M0.1%$38.77
33
2025-Q2
Increased
623,689
+56.0%
$17.3M0.1%$28.04
40
2025-Q1
Increased
399,743
+30.2%
$8.9M0.0%$23.09
35
2024-Q4
Decreased
306,946
-5.3%
$6.1M0.0%$19.60
0
2024-Q3
Increased
324,064
+40.2%
$8.1M0.0%$25.00
36
2024-Q2
New
231,079
-
$4.3M0.0%$18.67
37

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used